0

breast cancer stage 2 chemotherapy

báo cáo hóa học:

báo cáo hóa học:" Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer" pdf

Hóa học - Dầu khí

... 22 96,88 23 10,09 3,37 6 .25 e-14 1.88e-11 78% D 25 54.37 25 40. 32 2568.41 7.16 4.13e-07 1 .24 e-04 1% U 28 45.58 28 38.34 28 52. 81 3.69 3.59e- 12 1.08e-09 21 % D 28 65.54 28 64.46 28 66. 62 7.73 4.19e -20 1 .26 e-17 ... 15.83 024 .45 11.71 0.073 32. 8 324 9.64 5 .24 0.075 12. 4N – nodal status N0 (n = 63)vs. N1 (n = 20 )8618 .25 10.83 0. 024 45.186 02. 25 29 .35 0.036 29 .5 29 09.04 10.58 0.038 32. 58607.98 5.60 0.040 25 .786 82. 92 ... 19.94098.35 25 .90 0.0 32 22. 53 024 .45 11.71 0.035 20 .2 4070.43 5.58 0.048 19 .2 T – primary tumor size T1 (n = 44)vs. T2 (n = 40)5353.64 11.54 0.033 21 .9 28 73.93 7.13 0.038 20 .55343.98 6 .26 0.051...
  • 13
  • 506
  • 0
Báo cáo hóa học:

Báo cáo hóa học: " Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer" pot

Hóa học - Dầu khí

... (fr.4 02- 478) D 0.039 0 .20 6 0.1 52 8,931 C3 (fr.6 72- 747) D 0.039 0 .23 8 0.1068,9 42 APOA2 (fr .24 -100) D 0. 024 0.084 0 .20 48,973 - D 0. 024 0.099 0.1939,419 APOC3 (fr .21 -99) I 0. 024 0.084 0 .20 79,519 ... Consensus on the Primary Therapy of Early Breast Cancer 20 09. Ann Oncol 20 09, 20 :1319-1 329 .4. Hanash S: Disease proteomics. Nature 20 03, 422 :22 6 -23 2.5. Wulfkuhle JD, Liotta LA, Petricoin EF: ... therapyOnly surgery 2, 7 42 0.050 0.118 0 .27 53 ,26 3 FGA (fr.576-604) I 0.053 0.084 0.5063,3 02 - I 0.039 0 .23 8 0.1503,9 92 - D 0.039 0.136 0.1 82 4,038 - I 0.099 0.099 0.5104, 524 APP (fr.6 72- 713) D 0.053...
  • 11
  • 391
  • 0
Báo cáo sinh học:

Báo cáo sinh học: " Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure" potx

Hóa học - Dầu khí

... June C, Zhang PJ:Targeting HER -2/ neu in early breast cancer development using dendriticcells with staged interleukin- 12 burst secretion. Cancer Res 20 07,67:18 42- 18 52. 8. Matkowski R, Gisterek ... human breast cancer. Breast 20 08,17:604-610.10. Kominsky SL, Hobeika AC, Lake FA, Torres BA, Johnson HM: Down-regulation of neu/HER -2 by interferon-gamma in prostate cancer cells. Cancer Res 20 00, ... progressed to HER -2/ neunegative breast cancer under HER -2/ neu-specific immune pressure.Methods: We conducted a pilot study in patients with HER -2/ neu positive and HER -2/ neu negative breast cancersas...
  • 5
  • 374
  • 0
báo cáo hóa học:

báo cáo hóa học:" Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure" pdf

Hóa học - Dầu khí

... progressed to HER -2/ neunegative breast cancer under HER -2/ neu-specific immune pressure.Methods: We conducted a pilot study in patients with HER -2/ neu positive and HER -2/ neu negative breast cancersas ... Massey Cancer Center, 401 College Street, Richmond VA 23 298,USA. 2 Department of Pathology, Virginia Commonwealth University Massey Cancer Center, 120 0 E. Marshall Street, Richmond VA 9806 62, USA.3Department ... patientsOf 12 patients with HER -2/ neu negative breast cancers(stages I-IIIA) ten patients showed HER -2/ neu-specificIFN-g producing T cell responses (Figure 1A). Allthree patients with HER -2/ neu...
  • 5
  • 289
  • 0
Báo cáo toán học:

Báo cáo toán học: "MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER" docx

Báo cáo khoa học

... treated for metastatic breast cancer in 4 French cancer centres. The diagnosis of metastasis was made between 19 92 and 20 02. A total of 7 72 patients received first-line chemotherapy [4]. Because ... Minjoz, 25 000 Besancon France. Xavier.pivot@univ-fcomte.fr Received: 20 08.03.13; Accepted: 20 08.05.04; Published: 20 08.05.05 The present study was conducted in patients with metastatic breast cancer. ... AM et al. Cancer incidence and mortality in France over the period 1978 -20 00. Rev Epidemiol Sante Publique 20 03;51(1 Pt 1):3-30 2. Dickson R, Pestell R, Lippman M. Metastatic breast cancer. ...
  • 6
  • 219
  • 0
báo cáo khoa học:

báo cáo khoa học: "Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study" pps

Báo cáo khoa học

... afterneo-adjuvant chemotherapy in locally advanced breast cancer - a prospective studyChintamani1 ,2* , Megha Tandon1 ,2 , Ashwani Mishra 2, 3, Usha Agarwal 2, 3, Sunita Saxena 2, 3AbstractBackground: ... ofSLNBBreslin TM et al[19 ,20 ]II/III Blue dye+/_radiocolloids51 25 84.3 12 AccurateNason KS et al [21 ] T1-T4, N0 Blue dye +radio colloid 15 9 86.7 33 InaccurateJulien TB et al [22 ] I/II, palpable ... with immediate pathologic review in patientsreceiving preoperative chemotherapy for breast carcinoma. Ann SurgOncol 20 02, 9 :24 3 -24 7.doi:10.1186/1477-7819-9-19Cite this article as: Chintamani...
  • 7
  • 303
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Bony metastases from breast cancer - a study of foetal antigen 2 as a blood tumour markerl" doc

Báo cáo khoa học

... practice.AbbreviationsFA -2: Foetal antigen 2; CA15.3: Cancer antigen 15.3; CEA: Carcinoembryonicantigen; PBC: Primary breast cancer; LAPC: Locally advanced primary breast cancer; ABC: Advanced breast cancer; ... in breast cancer. Anticancer Res 1996, 16 :22 89-93.11. Cheung KL, Graves CRL, Robertson JFR: Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 20 00, ... and womenwith breast cancer which was still confined to the breast (ie PBC and LAPC) (Tables 1 and 2) . Nevertheless, whenall stages of cancer were taken into consideration, FA -2 levels appeared...
  • 4
  • 286
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women" doc

Báo cáo khoa học

... ReferentAR1AR2 15 (21 .4%) 7 (8.7%) 0. 02 AR2AR2 25 (35.7%) 28 (35.0%) 0.47Table 4 Association of AR-CAG polymorphism with breast cancer (matched analysis)Control OR (95% CI), pAR2 AR1Case AR2 18 21 ... onset (20 ) 8 (40, 22 .2) 22 (44, 64.8) 1.000 0.397 1.000 0.160Early onset (50) 28 (56, 77.8) 12 (60, 35 .2) 0.786 (0.450, 1.373) 0.454 (0.151, 1.365)Family HistoryNo FH (59) 30 (50.8, 83.3) 29 (49 .2, ... (0.188, 2. 3 62) Negative (26 ) 12 (46 .2, 66.7) 14 (53.8, 77.8)Androgen receptor status N = 20 N = 26 1.000Positive (16) 8 (50, 40) 8 (50, 30.7) 0.668 (0.196, 2. 263) 0.516Negative (30) 12 (40,...
  • 9
  • 508
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Intraoperative radiation therapy in the treatment of early-stage breast cancer utilizing xoft axxent electronic brachytherapy" ppt

Báo cáo khoa học

... brachytherapy. In thisPublished: 2 March 20 09World Journal of Surgical Oncology 20 09, 7 :24 doi:10.1186/1477-7819-7 -24 Received: 17 December 20 08Accepted: 2 March 20 09This article is available ... conventional postopera-tive whole -breast radiotherapy after breast- conservingsurgery for the management of early -stage invasive breast cancer (a trial update). Amer J Surg 20 07, 194:507-510.19. Vaidya ... report of intra-operative radiotherapy (IORT) in limited -stage breast can-cers that are conservatively treated. Eur J Cancer 20 01,37(17) :21 78 -21 83.18. Holmes DR, Baum M, Joseph D: The targit trial:...
  • 6
  • 499
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "The combination effect of sodium butyrate and 5-Aza-2''''-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines" pot

Báo cáo khoa học

... 7p16INK4a 95 5 63/63 30 40 72 7E-cadherin 95 5 55/57 30 40 72 7MINT1(M1) 95 5 52/ 52 30 37 72 7MINT2(M2) 95 5 59/59 30 40 72 7MINT31(M31) 95 5 62/ 60 30 38 72 7Table 2: MS-PCR primers of specific ... deacetylaseinhibition. Int J Radiat Oncol Biol Phys 20 05, 62: 223 -22 9. 24 . Takebayashi S, Nakao M, Fujita N, Sado T, Tanaka M, Taguchi H, Oku-mura K: 5-aza -2& apos;-deoxycytidine induces histone hyperacetyla-tion ... treatment of cancer. Nat Rev Drug Discov. 20 02, 1(4) :28 7 -29 9.17. Brown CE, Lechner T, Howe L, Workman JL: The many HATs oftranscription coactivators. Trends Biochem Sci 20 00, 25 :15-19.18....
  • 7
  • 327
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer" ppsx

Báo cáo khoa học

... Global cancer statistics, 20 02. CA Cancer J Clin 20 05, 55 (2) :74-108. 2. Zheng Y, Li DL, Xiang YM, Li XJ: The status and trend of breast cancer incidence in Shanghai. J Surg Concepts Pract 20 01,6 :21 9 -22 1.3. ... amplified Her -2 FISH non-amplified Concordance by IHC Discordance by IHC0 and 1+ (n = 26 ) 5 21 (21 /26 )80.8% (5 /26 )19 .2% 2+ (n = 10) 7 3 (7/10)70.0% (3/10)30.0%3+ (n = 14) 13 1 (13/14) 92. 9% (1/14)7.1%IHC ... Peng JW: Erb-b2amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+ in immunohistochemical analy-sis. Am J Clin Pathol 20 05, 124 (1):97-1 02. 22 . Kuo SJ, Wang...
  • 6
  • 360
  • 0
Báo cáo khoa học:

Báo cáo khoa học: " Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity" potx

Báo cáo khoa học

... (cm3)P‡DHIP‡SkinYes* 11 (22 .9) 51.3 ± 12. 1 0 .22 1 25 .7 ± 6 .2 0 .22 2 0.51 ± 0.03 0.105No 37 (77.1) 43.0 ± 18.9 22 .0 ± 8.7 0.49 ± 0.03Subcutaneous tissueYes† 26 (54 .2) 50 .2 ± 18 .2 0.018 25 .1 ± 8.1 0.034 ... radical mastectomy for early breast cancer. N Engl J Med 20 02, 347: 122 7- 123 2.6. Morrow M: Rational local therapy for breast cancer. N Engl J Med 20 02, 347: 127 0- 127 1.7. Clarke M, Collins R, ... the use of breast- conserving therapy in stage I and II breast carcinoma. J Clin Oncol 20 01, 19 :22 54 -22 62. 4. Arthur DW, Vicini FA: Accelerated partial breast irradiation as a part of breast conservation...
  • 8
  • 339
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: Is there a role for radiation therapy" ppsx

Báo cáo khoa học

... 15 2 14Range (4-38) (6 -25 )≥ 25 % 20 8Extracapsular extension 26 39 10 42 Stage (Tumor size)IIA (T1N1) 13 20 9 37.5IIB (T2N1) 53 80 15 62. 5Tumor locationMedial 20 30 6 25 Central 16 24 6 25 Lateral ... RadiotherOncol 20 00, 55 :26 3 -27 2. 23 . Whelan TJ, Julian J, Wright J, et al: Does locoregional radiation therapyimprove survival in breast cancer? A meta-analysis. J Clin Oncol 20 00,18: 122 0- 122 9. 24 . Sotiriou ... DMrate ( 12% vs 42% , p = 0.004), 5 year DFS ( 82. 4% vs 52. 4%, p = 0.034, 42. 8 42- 1 32. 158 CI 95%), and 5 yearOS (90 .2% vs 61,9%, p = 0.087, 71. 127 -199.340 CI95%)(Figure 1, 2, 3) (Table 2) .There...
  • 8
  • 357
  • 0

Xem thêm